Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Alfred E Tiefenbacher (Gmbh & Co. Kg) is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The prosecution is overseen by 1 distinct examiner, PARK, HAEJIN S, who is also the busiest examiner with 1 pending office action. The portfolio's current activity is located in 1 distinct art unit, reflecting a specialized focus on pharmaceutical technology.
The presence of 1 pending office action indicates a narrow current engagement with the patent office. Practitioners should prioritize understanding the examination patterns of PARK, HAEJIN S, as she manages the entirety of the company's pending workload. The concentration in 1 distinct art unit within the Biotechnology & Pharmaceuticals sector suggests a targeted approach to securing intellectual property in this field. This data profile shows a streamlined prosecution path with a single examiner and a single active case, where the practitioner can focus on the specific procedural requirements of 1 distinct art unit to advance the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PARK, HAEJIN S | 1 | 55.1% | +38.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18713358 | GRANULES CONTAINING POSACONAZOLE | PARK, HAEJIN S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18713358 | GRANULES CONTAINING POSACONAZOLE | PARK, HAEJIN S | — |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18713358 | GRANULES CONTAINING POSACONAZOLE | PARK, HAEJIN S | 1614 | §102§103§112 | Non-Final OA | — | Pending | May 24, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAlfred E Tiefenbacher (Gmbh & Co. Kg) has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Haejin S Park has the most, with 1 of Alfred E Tiefenbacher (Gmbh & Co. Kg)'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.